Hence, to build a progress in PCa therapy, it is essential to understand the detailed mechanisms accounting for anti-androgenic activity and resistance to AR antagonists and consequently to develop other strategies to overcome tumor growth progression. Here, AR is linked to posterior cortical atrophy.